13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000919574-25-003127
Total Value
$5.1M
Positions
12
Other Managers
0
Confidential Omitted
Yes
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | REZOLUTE INC | RZLT | 1,318,967 | $3.8M | 75.28% |
| 2 | SPDR GOLD TR | GLD | 1,298 | $374,101 | 7.36% |
| 3 | BERKSHIRE HATHAWAY INC DEL | BRK-A | 467 | $248,816 | 4.90% |
| 4 | MIND MEDICINE MINDMED INC | 60255C885 | 34,073 | $199,327 | 3.92% |
| 5 | BICARA THERAPEUTICS INC | BCAX | 10,941 | $142,562 | 2.81% |
| 6 | COMPASS THERAPEUTICS INC | CMPX | 43,465 | $82,584 | 1.63% |
| 7 | LEXEO THERAPEUTICS INC | LXEO | 17,851 | $61,943 | 1.22% |
| 8 | KYVERNA THERAPEUTICS INC | KYTX | 22,981 | $44,354 | 0.87% |
| 9 | CARDIFF ONCOLOGY INC | CRDF | 13,287 | $41,721 | 0.82% |
| 10 | INHIBIKASE THERAPEUTICS INC | IKT | 16,393 | $35,901 | 0.71% |
| 11 | ADICET BIO INC | ACET | 17,488 | $13,203 | 0.26% |
| 12 | CONTEXT THERAPEUTICS INC | CNTX | 18,403 | $11,263 | 0.22% |